Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 31

1.

VEGF-VEGF receptor complexes as markers of tumor vascular endothelium.

Brekken RA, Thorpe PE.

J Control Release. 2001 Jul 6;74(1-3):173-81. Review.

PMID:
11489493
2.

Vascular endothelial growth factor and vascular targeting of solid tumors.

Brekken RA, Thorpe PE.

Anticancer Res. 2001 Nov-Dec;21(6B):4221-9. Review.

PMID:
11908675
3.
4.

Lymphatic versus blood vascular endothelial growth factors and receptors in humans.

Partanen TA, Paavonen K.

Microsc Res Tech. 2001 Oct 15;55(2):108-21. Review.

PMID:
11596156
5.

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.

Shinkaruk S, Bayle M, Laïn G, Déléris G.

Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. Review.

PMID:
12678905
6.

VEGF receptor signaling and endothelial function.

Kliche S, Waltenberger J.

IUBMB Life. 2001 Jul;52(1-2):61-6. Review.

8.

VEGF antagonists.

Hasan J, Jayson GC.

Expert Opin Biol Ther. 2001 Jul;1(4):703-18. Review.

PMID:
11727506
9.

The role of vascular endothelial growth factor in angiogenesis.

Ferrara N, Gerber HP.

Acta Haematol. 2001;106(4):148-56. Review.

PMID:
11815711
10.

Clinical development of angiogenesis inhibitors to vascular endothelial growth factor and its receptors as cancer therapeutics.

Zhu Z, Bohlen P, Witte L.

Curr Cancer Drug Targets. 2002 Jun;2(2):135-56. Review.

PMID:
12188915
11.

Endothelial receptor tyrosine kinases involved in angiogenesis.

Mustonen T, Alitalo K.

J Cell Biol. 1995 May;129(4):895-8. Review. No abstract available.

12.

VEGF receptor signal transduction.

Matsumoto T, Claesson-Welsh L.

Sci STKE. 2001 Dec 11;2001(112):re21. Review.

PMID:
11741095
14.

[Receptors for factors of the VEGF (Vascular Endothelial Growth Family)].

Fournier E, Birnbaum D, Borg JP.

Bull Cancer. 1997 Apr;84(4):397-405. Review. French.

15.

The vascular endothelial growth factor family: signalling for vascular development.

Stacker SA, Achen MG.

Growth Factors. 1999;17(1):1-11. Review. No abstract available.

PMID:
10495958
16.

[Anti-angiogenic reagents].

Shibuya M.

Tanpakushitsu Kakusan Koso. 2000 Apr;45(6 Suppl):1182-7. Review. Japanese. No abstract available.

PMID:
10771693
17.

Inhibition of vascular endothelial growth factor receptor signaling in angiogenic tumor vasculature.

Backer MV, Hamby CV, Backer JM.

Adv Genet. 2009;67:1-27. doi: 10.1016/S0065-2660(09)67001-2. Review.

PMID:
19914448
18.

[VEGF].

Yoshiji H, Fukui H, Kuriyama S.

Nihon Rinsho. 2001 Oct;59 Suppl 6:189-94. Review. Japanese. No abstract available.

PMID:
11761939
19.

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy.

Witte L, Hicklin DJ, Zhu Z, Pytowski B, Kotanides H, Rockwell P, Böhlen P.

Cancer Metastasis Rev. 1998 Jun;17(2):155-61. Review.

PMID:
9770111
20.

Tumor vasculature targeted therapies: getting the players organized.

Molema G, Meijer DK, de Leij LF.

Biochem Pharmacol. 1998 Jun 15;55(12):1939-45. Review.

PMID:
9714313

Supplemental Content

Support Center